MCB's Molecular Therapeutics (MTx) division announced today the launch of the new Molecular Therapeutics Initiative (MTI) designed to accelerate drug discovery by tackling the "undruggable" & discovering new therapeutics modalities.
Department News
Below are articles from various sources about members of MCB and their research.
Congratulations to Assistant Professor of Cell Biology, Development and Physiology Meng-meng Fu and Assistant Professor of Genetics, Genomics, Evolution, and Development Dipti Nayak on being named 2024 Sloan Research Fellows.
Welcome to MCB's newest faculty member, Allon Wagner, who joined us as an assistant professor of immunology and molecular medicine on January 1st 2024. Wagner works at the intersection of computational single-cell genomics and immunometabolism.
Jennifer Doudna, professor of molecular therapeutics, was named a 2024 Society Fellow by the Biophysical Society. This award honors those who demonstrate excellence in science and was given for her development of a method for genome editing.
As the year comes to a close, MCB has a lot to be thankful for. Most importantly, we are grateful for our extraordinary community of our students, postdocs, staff, faculty, alumni and friends. We hope you enjoy our year-end video highlighting some of our 2023 memories together.
The University of California, Berkeley (UC Berkeley), the world’s premier public university, seeks a visionary, strategic, and inclusive leader as its next dean of the Division of Biological Sciences.
Professor of Genetics, Genomics, Evolution, and Development, Noah Whiteman, discusses nature's toxins on KQED on November 30th at 10 am PT.